Latest Clinical trial Stories
NBI-98854 Phase III Program Underway for Tardive Dyskinesia SAN DIEGO, Nov. 3, 2014 /PRNewswire/ -- Neurocrine Biosciences, Inc.
Velos recently activated its Investigational Drug System at The University of Texas MD Anderson Cancer Center FREMONT, Calif., Nov.
MONTREAL, Oct. 31, 2014 /CNW Telbec/ - JSS Medical Research Inc. is pleased to announce that founder and CEO Dr. John S.
Conference Call Scheduled for Monday, November 3, 2014 at 10:00 a.m. Eastern time JERUSALEM, October 31, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc.
SAN DIEGO, Oct. 31, 2014 /PRNewswire/ -- Mast Therapeutics, Inc.
DMG Productions explores the latest breakthroughs in health and medicine. Zug, Switzerland (PRWEB) October 30, 2014 PSI CRO (PSI) announced that they
DrugDev is sponsoring and providing speakers for the 13th Annual Partnerships in Clinical Trials Congress in Barcelona, 4-6 November.
LEXINGTON, Mass., Oct.
Conference call to be held on Thursday, October 30, 2014 at 4:30 p.m. Eastern Time BOTHELL, Wash., and VANCOUVER, British Columbia, Oct.
NOTTINGHAM, United Kingdom, Oct.